Raaj Medisafe India Ltd

Raaj Medisafe India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 2 January 2026. While the rating change occurred earlier this month, the analysis and financial metrics discussed here reflect the company’s current position as of 29 January 2026, providing investors with the latest insights into its performance and outlook.

Raaj Medisafe India Ltd has seen its investment rating upgraded from Sell to Hold as of 2 January 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality. This shift comes amid a backdrop of strong quarterly financial performance and a more constructive technical outlook, signalling cautious optimism for investors in the packaging sector.

Raaj Medisafe India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 January 2026, providing investors with the latest insights into its performance and outlook.

Raaj Medisafe, a microcap player in the packaging sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, offering investors a comprehensive view of its current standing.

Raaj Medisafe India, a key player in the packaging sector, has experienced a revision in market assessment driven by a combination of technical indicators and fundamental financial data. Despite demonstrating robust long-term growth and positive quarterly results, the stock’s recent performance and technical trends have influenced a nuanced shift in its evaluation metrics.

Raaj Medisafe India has encountered significant selling pressure today, with the stock registering a sharp decline of 5.00% and exhibiting a complete absence of buyers. This distress selling signals a challenging phase for the packaging company as it continues to underperform against key market benchmarks over multiple time frames.

Raaj Medisafe India has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buyers on the trading day. The packaging sector company’s shares opened sharply lower and remained at intraday lows, signalling distress selling and a lack of demand from investors.

Raaj Medisafe India Ltd has encountered severe selling pressure today, with the stock hitting its lower circuit and registering only sell orders in the queue. This extreme market behaviour signals distress selling and a lack of buyer interest, marking a challenging phase for the packaging sector company.

Raaj Medisafe India Ltd has entered a phase of extreme selling pressure, registering a lower circuit with only sell orders in the queue. The stock’s trading activity today signals distress selling, with no buyers present to absorb the supply, marking a significant moment for investors in the packaging sector.

Raaj Medisafe India Ltd, a microcap in the packaging sector, is experiencing notable buying activity despite a recent decline. While it has underperformed the Sensex over shorter periods, it has shown significant long-term growth. The stock is currently trading above some moving averages, indicating mixed momentum.

Raaj Medisafe India, a microcap in the packaging sector, reported strong financial results for the quarter ending September 2025, with significant growth in profit after tax and net sales. However, challenges include negative operating cash flow and a need for improved capital efficiency, alongside fluctuating stock performance compared to the Sensex.

Raaj Medisafe India Ltd., a Madhya Pradesh-based manufacturer of medical disposable devices, has delivered robust topline growth in FY25, with net sales surging 44.2% year-on-year to ₹62.00 crores. The micro-cap packaging company, with a market capitalisation of ₹103.00 crores, posted net profit of ₹6.00 crores for the full year, doubling from ₹3.00 crores in FY24. However, the stock has struggled in recent months, declining 13.81% over the past year whilst trading at ₹78.00, significantly below its 52-week high of ₹102.35.

Raaj Medisafe India Ltd is experiencing significant selling pressure, with a notable decline in its stock price. The company has faced consecutive losses, underperforming the Sensex and showing a downward trend over recent weeks and months. It is currently trading below key moving averages, reflecting bearish investor sentiment.

Raaj Medisafe India Ltd is experiencing notable buying activity, with a 3.27% increase today, contrasting with a decline in the Sensex. The stock has shown resilience over the long term, achieving a 500.85% rise over five years, despite recent fluctuations and a decline in the past three months.